Product News

Found 260,912 articles

• Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates

  5/8/2023

  Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, May 15, 2023 at 8:30 a.m. Eastern Daylight Time to review first-quarter 2023 financials and provide corporate updates.

• PharmAbcine to participate in BIO International Convention 2023

  5/8/2023

  PharmAbcine Inc. announced today that the company will participate in the upcoming BIO International Convention 2023.

• HeartSciences to Participate at the Inaugural EF Hutton Global Conference

  5/8/2023

  Heart Test Laboratories, Inc. today announces that CEO, Andrew Simpson, will participate at the Inaugural EF Hutton Global Conference being held May 10 – 11, 2023, at the Plaza Hotel in New York City.

• Benitec Biopharma to Present at the JMP Securities Life Sciences Conference

  5/8/2023

  Benitec Biopharma Inc. today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16th, 2023 at 2:00 pm.

• AltruBio Announces Poster Presentation at Digestive Disease Week Conference 2023

  5/8/2023

  AltruBio Inc. today announced that David T. Rubin, M.D., Professor of Medicine and Pathology at the University of Chicago and AltruBio Scientific Advisory Board member, will share a poster presentation on immune checkpoint enhancer (ICE), ALTB-168, during  Digestive Disease Week®, taking place at McCormick Place in Chicago, IL, from May 6-9, 2023.

• Cerevance to Present at the 2023 RBC Capital Markets Global Healthcare Conference

  5/8/2023

  Cerevance today announced that Craig Thompson, chief executive officer of Cerevance, will present at the upcoming 2023 RBC Capital Markets Global Healthcare Conference being held May 16-17, 2023.

• Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023Management to Host Conference Call

  5/8/2023

  Minerva Neurosciences, Inc. today announced that it will release first quarter 2023 financial results and business updates on Monday, May 15, 2023.

• Rallybio to Present at the JMP Securities 2023 Life Sciences Conference

  5/8/2023

  Rallybio Corporation today announced that company management will participate in a fireside chat at the JMP Securities 2023 Life Sciences Conference on Monday, May 15 at 2:30 p.m. ET in New York, NY.

• Cognito Therapeutics Announces Poster Presentations at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023 Meeting

  5/8/2023

  Cognito Therapeutics announced today two poster presentations at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023 Meeting, held May 7-10 in Boston, MA.

• Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference

  5/8/2023

  Bio-Rad Laboratories, Inc. today announced that the company’s management will participate in a fireside chat event during the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023, at 3:35 PM Eastern Time (12:35 PM Pacific Time).

• Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023

  5/8/2023

  Bausch Health Companies Inc. and its gastroenterology business, Salix Pharmaceuticals today will deliver a podium presentation of its research titled "Impact of Rifaximin Use During The 30-Day Post-Discharge Period Following an Overt Hepatic Encephalopathy Hospitalization on Healthcare Utilization And Costs" during Digestive Disease Week® (DDW) 2023, which will be held virtually and in-person in Chicago, IL through Tuesday, May 9, 2023.

• Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress

  5/8/2023

  Celcuity Inc. today announced publication of an abstract reporting updated results for treatment-naive patients from the Phase 1b study of gedatolisib, a pan-PI3K/mTOR inhibitor, in combination with palbociclib and letrozole in women with HR+/HER2- advanced breast cancer (ABC).

• OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time

  5/8/2023

  OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first quarter 2023 financial results after the close of the U.S. financial markets on Monday, May, 15th , 2023.

• Altimmune to Participate at Two Upcoming Investor Conferences - May 8, 2023

  5/8/2023

  Altimmune, Inc. today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences.

• Biosion Presents Discovery and Development Data at PEGS for its Anti-CD40 Agonistic Antibody

  5/8/2023

  Biosion USA , Inc.  today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the PEGS Boston conference to be held from May 15 to 19, 2023.

• Genprex to Participate and Present at Upcoming May Industry and Investor Conferences

  5/8/2023

  Genprex, Inc. today announced the Company's participation in the following upcoming industry and investor conferences to be held in May 2023.

• Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of Atrial Fibrillation with Rapid Ventricular Rate

  5/8/2023

  Milestone Pharmaceuticals Inc. today announced that the Company will host a virtual Key Opinion Leader (KOL) event on Monday, May 22, 2023 at 8:00 a.m. ET.

• REGENXBIO to Participate in Upcoming Investor Conferences - May 8, 2023

  5/8/2023

  REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences.

• Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

  5/8/2023

  Deciphera Pharmaceuticals, Inc. today announced that members of the management team will participate in a fireside chat at the JMP Securities Life Sciences Conference on Monday, May 15, 2023 at 2:30 PM ET in New York, NY.

• Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

  5/8/2023

  Olema Pharmaceuticals, Inc. today announced a poster presentation on OP-1250, the Company’s complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD) in development for the treatment of metastatic breast cancer, at the upcoming ESMO Breast Cancer Annual Congress 2023 taking place May 11-13, 2023, in Berlin, Germany.